 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
  |
 |
|||||||
|
|||
|
(BBH)
|
|
|
|
October 29, 2009 |
|
|
|
|
|
Sepracor Inc. (SEPR) is scheduled to be acquired by Dainippon Sumitomo Pharma Co. Ltd. effective 10/20/2009. Upon completion, SEPR will be deleted from the index. $138.00 in cash (6 shares in the index multiplied by the $23.00/share offer) will be added to the index until distributed by the Bank of NY Mellon on ex-date 10/29/2009.
|
||
|
October 20, 2009 |
Sepracor Inc. |
SEPR |
|
|
|
Sepracor Inc. (SEPR) is scheduled to be acquired by Dainippon Sumitomo Pharma Co. Ltd. effective 10/20/2009. Upon completion, SEPR will be deleted from the index. $138.00 in cash (6 shares in the index multiplied by the $23.00/share offer) will be added to the index until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
April 01, 2009 |
|
|
|
|
|
Genentech Inc. (DNA) is scheduled to be acquired by Roche Holding AG effective 3/27/2009. Upon completion, DNA will be deleted from the index. $8,360.00 in cash (88 shares in index multiplied by $95.00/share offer) will be held in the index until distributed by the Bank of NY Mellon on ex-date 4/1/2009.
|
||
|
March 27, 2009 |
Genentech Inc. |
DNA |
|
|
|
Genentech Inc. (DNA) is scheduled to be acquired by Roche Holding AG effective 3/27/2009. Upon completion, DNA will be deleted from the index. $8,360.00 in cash (88 shares in index multiplied by $95.00/share offer) will be held in the index until distributed by the Bank of NY Mellon on an ex-date TBA.
|
||
|
December 03, 2008 |
|
|
|
|
|
Update to Cash Amount Applied Biosystems Inc. (ABI) is scheduled to be acquired by Invitrogen Corp. (IVGN) effective 11/24/2008. As per the mixed election option, ABI shareholders will receive $18.149433 in cash and 0.4543 shares of Invitrogen Corp. (IVGN). In addition, IVGN will be changing its Name, Symbol, and CUSIP to Life Technologies Corp. (LIFE). ABI will be deleted from the index effective 11/24/2008. In addition, $326.689794 in cash ($18.149433 offer multiplied by 18 shares in the index) will be added to the index until distributed by the Bank of NY on ex-date 12/3/2008. Finally, 8.1774 shares of Life Technologies Corp. (LIFE; formerly IVGN) will be added into the index effective 11/24/2008 (0.4543 IVGN share offer multiplied by 18 shares in the index).
|
||
|
October 06, 2008 |
Shire Limited American Depositary Shares |
SHPGY |
|
|
|
Name change only.
|
||
|
July 01, 2008 |
Applera Corp. - Celera Group |
CRA |
|
|
|
Applera Corp. - Celera Group (CRA) will be undergoing a reclassification of shares through a mandatory exchange from tracking stock to common shares effective 7/1/2008. As a result, its name and CUSIP will change. There will be no change in symbol. In addition, CRA will be changing its primary listing to NASDAQ effective for 7/1/2008.
|
||
|
May 21, 2008 |
|
|
|
|
|
Millennium Pharmaceuticals Inc. (MLNM) is scheduled to be acquired by Takeda Pharmaceutical Company Ltd. (4502.T) effective 5/14/2008. Upon completion, MLNM will be deleted from the index. $300.00 in cash (12 shares in index multiplied by $25/share cash tender offer) will be held in the index until distributed by the Bank of NY on ex-date 5/21/2008.
|
||
|
May 14, 2008 |
Millennium Pharmaceuticals Inc. |
MLNM |
|
|
|
Millennium Pharmaceuticals Inc. (MLNM) is scheduled to be acquired by Takeda Pharmaceutical Company Ltd. (4502.T) effective 5/14/2008. Upon completion, MLNM will be deleted from the index. $300.00 in cash (12 shares in index multiplied by $25/share cash tender offer) will be held in the index until distributed by the Bank of NY on an ex-date TBA.
|
||
|
June 27, 2007 |
|
|
|
|
|
Cash component updated to reflect the last traded price of MEDI MedImmune Inc. (MEDI) is scheduled to be acquired by AstraZeneca plc (AZN) effective 6/1/2007. Upon completion, MEDI will be deleted from the index. $869.55 in cash will be held in the index (Shares X Last Price) until distributed by the Bank of New York on ex-date 6/27/2007.
|
||
|
June 01, 2007 |
MedImmune Inc. |
MEDI |
|
|
|
MedImmune Inc. (MEDI) is scheduled to be acquired by AstraZeneca plc (AZN) effective 6/1/2007. Upon completion, MEDI will be deleted from the index. $868.20 in cash will be held in the index (Shares X Last Price) until distributed by the Bank of New York on an ex-date TBA.
|
||
|
February 05, 2007 |
ICOS Corp. |
ICOS |
|
|
|
ICOS Corp. (ICOS) is scheduled to be acquired by Eli Lilly & Co. (LLY) effective 1/31/2007. Upon completion, ICOS will be deleted from the index. There are 4 shares in the index. $136 cash will be held in the index until distrubuted on ex-date 2/5/07.
|
||
|
January 31, 2007 |
ICOS Corp. |
ICOS |
|
|
|
ICOS Corp. (ICOS) is scheduled to be acquired by Eli Lilly & Co. (LLY) effective 1/31/2007. Upon completion, ICOS will be deleted from the index.
|
||
|
January 31, 2007 |
ICOS Corp. |
ICOS |
|
|
|
ICOS Corp. (ICOS) is scheduled to be acquired by Eli Lilly & Co. (LLY) effective 1/31/2007. Upon completion, ICOS will be deleted from the index.
|
||
|
April 26, 2006 |
Chiron Corp. |
CHIR |
|
|
|
The merger consideration of $768.00 in the index will be removed on 4/26/06. Chiron Corp. (CHIR) is scheduled to be acquired by Novartis AG effective 4/20/2006. Chir shareholders will receive $48.00 per CHIR share held. $768.00 will be included in the index to account for the merger consideration until distributed by Bank of New York on an ex-date 4/26/06.
|
||
|
April 20, 2006 |
Chiron Corp. |
CHIR |
|
|
|
Chiron Corp. (CHIR) is scheduled to be acquired by Novartis AG effective 4/20/2006. Chir shareholders will receive $48.00 per CHIR share held. $768.00 will be included in the index to account for the merger consideration until distributed by Bank of New York on an ex-date TBA.
|
||
|
April 20, 2006 |
Chiron Corp. |
CHIR |
|
|
|
Chiron Corp. (CHIR) is scheduled to be acquired by Novartis AG effective 4/20/2006. Chir shareholders will receive $48.00 per CHIR share held. $768.00 will be included in the index to account for the merger consideration until distributed by Bank of New York on an ex-date TBA.
|
||
|
December 11, 2002 |
Enzon Inc. |
ENZN |
|
|
|
|
||
|
July 16, 2002 |
Immunex Corp. |
IMNX |
|
|
|
Amgen Inc. (AMGN) completed its acquisition of Immunex Corp. (IMNX). Under the terms of the merger agreement each share of IMNX will be converted into 0.44 AMGN shares and $4.50. There were 42 shares of IMNX in the Index. As a result of the merger, 18.48 additional shares of AMGN will be added to the index. In addition, $189 in cash will be included in the IBH Index until the HOLDRs distribute the cash portion of the merger consideration.
|
||
|
July 16, 2002 |
Amgen Inc |
AMGN |
|
|
|
Amgen Inc. (AMGN) completed its acquisition of Immunex Corp. (IMNX). Under the terms of the merger agreement each share of IMNX will be converted into 0.44 AMGN shares and $4.50. There were 42 shares of IMNX in the Index. As a result of the merger, 18.48 additional shares of AMGN will be added to the index. In addition, $189 in cash will be included in the IBH Index until the HOLDRs distribute the cash portion of the merger consideration.
|
||
|
May 14, 2001 |
Biochem Pharma Inc. |
BCHE |
|
|
|
Biochem Pharma Inc. (BCHE) is expected to merge with and into Shire Pharmaceuticals Group PLC. The exchange ratio will be 2.2757.
|
||
|
May 14, 2001 |
Shire Pharmaceuticals Group ADSs |
SHPGY |
|
|
|
Biochem Pharma Inc. (BCHE) is expected to merge with and into Shire Pharmaceuticals Group PLC. The exchange ratio will be 2.2757.
|
||
|
November 30, 2000 |
PE Corp.-PE Biosystems Group |
PEB |
|
|
|
New CUSIP: 038020103
|
||
|
November 30, 2000 |
PE Corp.-Celera Genomics Group |
CRA |
|
|
|
New CUSIP: 69332S201
|
||
|
June 01, 2000 |
QLT Phototherapeutics Inc. |
QLTI |
|
|
|
|
||
